Skip to content
value.today

Pristine Surgical LLC

Formerly Giteliscope Group, LLC

Total raised
$14 M
1 round on record
Latest round
$14 M
Nov 2021
First round on record
Nov 2021
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Pristine Surgical LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2021$14 MNo. 1$10 to $50 million

Pristine Surgical LLC: Raise no. 1, Nov 2021

Investors in this round

10 investors had bought by the notice of Jan 10, 2022: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $15 M offered; $1 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,411,772
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Bryan Lord · Executive Officer
  • Grant F. Little, III · Executive Officer
  • Siddharth F. Desai · Executive Officer
  • Stephen F. Snyder · Executive Officer
  • Anthony F. Savino · Director
  • David F. Matlin · Director
  • David F. Springer · Director
  • Garth F. Greimann · Director
  • Howard F. Freedberg · Director
  • Ivan F. Delevic · Director
  • Michael F. MacKinnon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Aegis Capital Corp. (CRD 15007) · New York, New YorkSold in NY
  • Ceros Financial Services, Inc. (CRD 37869) · Rockville, MarylandSold in VA

Signed by Bryan Lord, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 10, 2022. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pristine Surgical LLC chose not to state its revenue in its newest notice of a funding round (Jan 2022).

    SEC Form D · Jan 2022

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2022

That is all the official record says: Pristine Surgical LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Pristine Surgical LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pristine Surgical LLC
NameRoleNamed in
Bryan LordExecutive officerJan 2022
Grant F. Little, IIIExecutive officerJan 2022
Siddharth F. DesaiExecutive officerJan 2022
Stephen F. SnyderExecutive officerJan 2022
Anthony F. SavinoDirectorJan 2022
David F. MatlinDirectorJan 2022
David F. SpringerDirectorJan 2022
Garth F. GreimannDirectorJan 2022
Howard F. FreedbergDirectorJan 2022
Ivan F. DelevicDirectorJan 2022
Michael F. MacKinnonDirectorJan 2022